Medical - Devices
Compare Stocks
4 / 10Stock Comparison
EDAP vs AEYE vs ALKT vs ISRG
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Application
Medical - Instruments & Supplies
EDAP vs AEYE vs ALKT vs ISRG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Devices | Software - Application | Software - Application | Medical - Instruments & Supplies |
| Market Cap | $156M | $100M | $1.87B | $161.07B |
| Revenue (TTM) | $70M | $40M | $472M | $10.58B |
| Net Income (TTM) | $-13M | $-3M | $-50M | $2.98B |
| Gross Margin | 46.8% | 78.3% | 57.4% | 66.3% |
| Operating Margin | -38.2% | -7.9% | -9.3% | 30.5% |
| Forward P/E | — | — | 21.7x | 43.8x |
| Total Debt | $28M | $721K | $354M | $303M |
| Cash & Equiv. | $17M | $5M | $63M | $3.37B |
EDAP vs AEYE vs ALKT vs ISRG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| Edap Tms S.a. (EDAP) | 100 | 60.5 | -39.5% |
| AudioEye, Inc. (AEYE) | 100 | 32.0 | -68.0% |
| Alkami Technology, … (ALKT) | 100 | 36.5 | -63.5% |
| Intuitive Surgical,… (ISRG) | 100 | 157.3 | +57.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EDAP vs AEYE vs ALKT vs ISRG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EDAP has the current edge in this matchup, primarily because of its strength in stability and momentum.
- Beta 0.77 vs AEYE's 2.29
- +80.9% vs ALKT's -37.8%
AEYE is the clearest fit if your priority is income & stability.
- Dividend streak 1 yrs, beta 2.29
ALKT is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 32.9%, EPS growth -12.2%, 3Y rev CAGR 29.5%
- 32.9% revenue growth vs EDAP's 10.3%
- Lower P/E (21.7x vs 43.8x)
ISRG is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 5.5% 10Y total return vs EDAP's 18.9%
- Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
- Beta 1.02, current ratio 4.87x
- 28.2% margin vs EDAP's -18.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.9% revenue growth vs EDAP's 10.3% | |
| Value | Lower P/E (21.7x vs 43.8x) | |
| Quality / Margins | 28.2% margin vs EDAP's -18.9% | |
| Stability / Safety | Beta 0.77 vs AEYE's 2.29 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +80.9% vs ALKT's -37.8% | |
| Efficiency (ROA) | 14.8% ROA vs EDAP's -18.8%, ROIC 15.0% vs -69.2% |
EDAP vs AEYE vs ALKT vs ISRG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EDAP vs AEYE vs ALKT vs ISRG — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ISRG leads in 3 of 6 categories
ALKT leads 1 • EDAP leads 1 • AEYE leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
ISRG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ISRG is the larger business by revenue, generating $10.6B annually — 262.5x AEYE's $40M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to EDAP's -18.9%. On growth, EDAP holds the edge at +31.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $70M | $40M | $472M | $10.6B |
| EBITDAEarnings before interest/tax | -$24M | -$504,000 | -$12M | $3.8B |
| Net IncomeAfter-tax profit | -$13M | -$3M | -$50M | $3.0B |
| Free Cash FlowCash after capex | -$17M | $2M | $44M | $2.8B |
| Gross MarginGross profit ÷ Revenue | +46.8% | +78.3% | +57.4% | +66.3% |
| Operating MarginEBIT ÷ Revenue | -38.2% | -7.9% | -9.3% | +30.5% |
| Net MarginNet income ÷ Revenue | -18.9% | -7.6% | -10.6% | +28.2% |
| FCF MarginFCF ÷ Revenue | -25.1% | +5.5% | +9.4% | +26.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +31.4% | +7.9% | +28.9% | +23.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.3% | +29.0% | -22.7% | +18.8% |
Valuation Metrics
ALKT leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $156M | $100M | $1.9B | $161.1B |
| Enterprise ValueMkt cap + debt − cash | $166M | $96M | $2.2B | $158.0B |
| Trailing P/EPrice ÷ TTM EPS | -5.33x | -32.36x | -37.89x | 57.62x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 21.69x | 43.84x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 2.65x |
| EV / EBITDAEnterprise value multiple | — | — | — | 43.62x |
| Price / SalesMarket cap ÷ Revenue | 2.20x | 2.49x | 4.20x | 16.00x |
| Price / BookPrice ÷ Book value/share | 8.02x | 20.91x | 5.00x | 9.17x |
| Price / FCFMarket cap ÷ FCF | — | — | 45.09x | 64.67x |
Profitability & Efficiency
ISRG leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-65 for EDAP. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to EDAP's 1.43x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs ALKT's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -65.4% | -47.8% | -14.0% | +16.9% |
| ROA (TTM)Return on assets | -18.8% | -9.5% | -5.9% | +14.8% |
| ROICReturn on invested capital | -69.2% | -42.4% | -8.6% | +15.0% |
| ROCEReturn on capital employed | -56.0% | -17.7% | -9.3% | +16.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 3 | 6 |
| Debt / EquityFinancial leverage | 1.43x | 0.15x | 0.98x | 0.02x |
| Net DebtTotal debt minus cash | $10M | -$5M | $290M | -$3.1B |
| Cash & Equiv.Liquid assets | $17M | $5M | $63M | $3.4B |
| Total DebtShort + long-term debt | $28M | $721,000 | $354M | $303M |
| Interest CoverageEBIT ÷ Interest expense | -16.21x | -2.79x | -3.73x | — |
Total Returns (Dividends Reinvested)
ISRG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $3,977 for AEYE. Over the past 12 months, EDAP leads with a +80.9% total return vs ALKT's -37.8%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs EDAP's -28.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +22.4% | -18.7% | -23.1% | -19.3% |
| 1-Year ReturnPast 12 months | +80.9% | -27.9% | -37.8% | -15.4% |
| 3-Year ReturnCumulative with dividends | -63.3% | +20.6% | +41.1% | +49.6% |
| 5-Year ReturnCumulative with dividends | -37.8% | -60.2% | -54.9% | +58.7% |
| 10-Year ReturnCumulative with dividends | +18.9% | +102.2% | -59.5% | +554.2% |
| CAGR (3Y)Annualised 3-year return | -28.4% | +6.4% | +12.2% | +14.4% |
Risk & Volatility
EDAP leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
EDAP is the less volatile stock with a 0.77 beta — it tends to amplify market swings less than AEYE's 2.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EDAP currently trades 82.4% from its 52-week high vs AEYE's 49.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.77x | 2.29x | 1.30x | 1.02x |
| 52-Week HighHighest price in past year | $5.05 | $16.39 | $31.66 | $603.88 |
| 52-Week LowLowest price in past year | $1.21 | $5.31 | $14.11 | $427.84 |
| % of 52W HighCurrent price vs 52-week peak | +82.4% | +49.4% | +55.1% | +75.1% |
| RSI (14)Momentum oscillator 0–100 | 54.8 | 61.3 | 50.9 | 42.4 |
| Avg Volume (50D)Average daily shares traded | 38K | 194K | 1.9M | 1.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: EDAP as "Buy", ALKT as "Buy", ISRG as "Buy". Consensus price targets imply 44.2% upside for EDAP (target: $6) vs 26.2% for ALKT (target: $22).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Buy | Buy |
| Price TargetConsensus 12-month target | $6.00 | — | $22.00 | $622.60 |
| # AnalystsCovering analysts | 8 | — | 12 | 55 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | 1 | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +1.4% |
ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ALKT leads in 1 (Valuation Metrics).
EDAP vs AEYE vs ALKT vs ISRG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EDAP or AEYE or ALKT or ISRG a better buy right now?
For growth investors, Alkami Technology, Inc.
(ALKT) is the stronger pick with 32. 9% revenue growth year-over-year, versus 10. 3% for Edap Tms S. a. (EDAP). Intuitive Surgical, Inc. (ISRG) offers the better valuation at 57. 6x trailing P/E (43. 8x forward), making it the more compelling value choice. Analysts rate Edap Tms S. a. (EDAP) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EDAP or AEYE or ALKT or ISRG?
On forward P/E, Alkami Technology, Inc.
is actually cheaper at 21. 7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — EDAP or AEYE or ALKT or ISRG?
Over the past 5 years, Intuitive Surgical, Inc.
(ISRG) delivered a total return of +58. 7%, compared to -60. 2% for AudioEye, Inc. (AEYE). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus ALKT's -59. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EDAP or AEYE or ALKT or ISRG?
By beta (market sensitivity over 5 years), Edap Tms S.
a. (EDAP) is the lower-risk stock at 0. 77β versus AudioEye, Inc. 's 2. 29β — meaning AEYE is approximately 199% more volatile than EDAP relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 143% for Edap Tms S. a. — giving it more financial flexibility in a downturn.
05Which is growing faster — EDAP or AEYE or ALKT or ISRG?
By revenue growth (latest reported year), Alkami Technology, Inc.
(ALKT) is pulling ahead at 32. 9% versus 10. 3% for Edap Tms S. a. (EDAP). On earnings-per-share growth, the picture is similar: AudioEye, Inc. grew EPS 30. 6% year-over-year, compared to -52. 9% for Edap Tms S. a.. Over a 3-year CAGR, ALKT leads at 29. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EDAP or AEYE or ALKT or ISRG?
Intuitive Surgical, Inc.
(ISRG) is the more profitable company, earning 28. 4% net margin versus -41. 5% for Edap Tms S. a. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -35. 6% for EDAP. At the gross margin level — before operating expenses — AEYE leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EDAP or AEYE or ALKT or ISRG more undervalued right now?
On forward earnings alone, Alkami Technology, Inc.
(ALKT) trades at 21. 7x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 22. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EDAP: 44. 2% to $6. 00.
08Which pays a better dividend — EDAP or AEYE or ALKT or ISRG?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is EDAP or AEYE or ALKT or ISRG better for a retirement portfolio?
For long-horizon retirement investors, Intuitive Surgical, Inc.
(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +554. 2% 10Y return). AudioEye, Inc. (AEYE) carries a higher beta of 2. 29 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +554. 2%, AEYE: +102. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EDAP and AEYE and ALKT and ISRG?
These companies operate in different sectors (EDAP (Healthcare) and AEYE (Technology) and ALKT (Technology) and ISRG (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EDAP is a small-cap quality compounder stock; AEYE is a small-cap quality compounder stock; ALKT is a small-cap high-growth stock; ISRG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.